MGRM Directors File Initial Ownership Forms, May 07, 2026

Insider trading filings reveal a fascinating pattern: when company leaders first disclose their holdings, it signals transparency and regulatory compliance. But what does it really mean for shareholders? Today we examine two initial ownership filings from MGRM directors. Gray Colleen and Van Kirk Richard Lee Jr both filed Form 3 disclosures in late 2025, revealing their stock option holdings. These filings don’t indicate buying or selling activity. Instead, they represent the directors’ first formal disclosure of existing equity stakes to the SEC. Understanding these initial ownership filings helps investors gauge leadership alignment and governance transparency at Monogram Orthopaedics, Inc.

What Are Form 3 Initial Ownership Filings?

Form 3 filings are the first step in insider disclosure. Directors and officers must file them within 10 days of joining a company or taking on a new role. These forms reveal what equity stakes insiders already hold, not new transactions.

Understanding Initial Ownership Disclosures

Form 3 filings establish a baseline for tracking insider activity. They show existing holdings of common stock, options, and other securities. The SEC requires these filings to create a public record of leadership equity stakes. This transparency helps investors understand potential conflicts of interest and alignment with shareholders.

Why These Filings Matter

Initial ownership disclosures set the foundation for future Form 4 filings, which track actual buying and selling. When directors file Form 3, they’re essentially saying: “Here’s what I own today.” Future transactions get compared against this baseline. This creates accountability and helps detect unusual trading patterns over time.

Gray Colleen’s Director Holdings at MGRM

Gray Colleen, serving as a director at Monogram Orthopaedics, filed her initial ownership disclosure on October 14, 2025. Her filing revealed significant equity exposure through stock options.

Option Holdings and Strike Price

Colleen disclosed 3,000 options to acquire common stock at a strike price of $4.00 per share. This represents a potential value of $12,000 if exercised at the stated price. The transaction date listed as November 30, 2030 reflects the option vesting or grant date. These options give Colleen the right to purchase shares at a fixed price, aligning her interests with long-term stock performance.

Director Alignment Signal

When directors hold substantial option grants, it signals confidence in the company’s future. Colleen’s 3,000 options represent meaningful skin in the game. This equity stake encourages her to make decisions that benefit shareholders. The SEC filing for Gray Colleen provides full details on her holdings and compensation structure.

Van Kirk Richard Lee Jr’s Director Position and Options

Van Kirk Richard Lee Jr, also serving as a director, filed his initial ownership disclosure on September 30, 2025. His filing documented a smaller but still meaningful equity stake in the company.

Option Grant Details

Lee Jr disclosed 2,000 options to acquire common stock at $2.00 per share. This represents a potential value of $4,000 at the stated strike price. The transaction date of July 31, 2027 indicates when these options were granted or became exercisable. Like Colleen’s holdings, these options tie Lee Jr’s compensation to shareholder value creation.

Comparative Director Stakes

Lee Jr’s 2,000 options are smaller than Colleen’s 3,000, suggesting different compensation structures or tenure levels. Both directors hold options rather than outright shares, which is typical for newly appointed board members. The SEC filing for Van Kirk Richard Lee Jr contains complete details on his option holdings and vesting schedule.

What This Means for MGRM Shareholders

These two Form 3 filings paint a picture of director equity alignment at Monogram Orthopaedics. Combined, the directors hold 5,000 options worth approximately $16,000 at current strike prices. This represents meaningful but not massive personal stakes.

Governance and Transparency

Form 3 filings demonstrate that MGRM maintains proper governance standards. Directors are disclosing their holdings as required by law. This transparency builds investor confidence and shows regulatory compliance. Meyka AI rates MGRM a grade of B, reflecting solid fundamentals and governance practices. The company’s market cap of $243.8 million suggests a mid-cap orthopaedics player with established operations.

Future Monitoring

Investors should monitor future Form 4 filings from these directors. Form 4 filings will show if Colleen and Lee Jr buy, sell, or exercise their options. Unusual trading patterns could signal management concerns or confidence shifts. Regular monitoring of insider activity helps investors stay informed about leadership sentiment.

Final Thoughts

Gray Colleen and Van Kirk Richard Lee Jr’s Form 3 filings represent routine but important governance disclosures at Monogram Orthopaedics. Combined, they hold 5,000 stock options worth $16,000, demonstrating director alignment with shareholder interests. These initial ownership filings establish a baseline for tracking future insider activity. While these filings don’t indicate buying or selling, they signal that MGRM maintains proper SEC compliance and transparency standards. Investors should continue monitoring Form 4 filings for actual trading activity from these directors.

FAQs

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes. Insider trading data is sourced from public SEC filings. This is not financial advice. Always conduct your own research and consult a licensed financial advisor before making investment decisions.